secwatch.observer — SEC 8-K summary
======================================

Issuer:     LABCORP HOLDINGS INC. (LH)
CIK:        0000920148
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0000920148-23-000031
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Labcorp promotes Mark Schroeder to President Diagnostics & COO; salary $650K plus equity
--------------------------------------------------------------------------------

- Mark Schroeder appointed EVP, President Diagnostics & COO effective May 1, 2023, as part of planned spin-off of Clinical Development business.
- Previously served as EVP, President Diagnostics Laboratory Operations and Global Supply Chain.
- Base salary increased to $650,000; receives RSU and PSU awards each valued at $100,000 and stock option award valued at $300,000.
- Equity awards granted on May 5, 2023; spin-off previously announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/920148/000092014823000031/0000920148-23-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/920148/000092014823000031/lh-20230501.htm
  HTML page:      https://secwatch.observer/filing/0000920148-23-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer